Morse MA - Search Results

1

A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen.

Morse MA, Deng Y, Coleman D, Hull S, Kitrell-Fisher E, Nair S, Schlom J, Ryback ME, Lyerly HK. Morse MA, et al. Clin Cancer Res. 1999 Jun;5(6):1331-8. Clin Cancer Res. 1999. PMID: 10389916 Clinical Trial.

2

Immunotherapy of cancer using dendritic cells.

Morse MA, Lyerly HK. Morse MA, et al. Cytokines Cell Mol Ther. 1998 Mar;4(1):35-44. Cytokines Cell Mol Ther. 1998. PMID: 9557215 Review.

3

Optimization of the sequence of antigen loading and CD40-ligand-induced maturation of dendritic cells.

Morse MA, Lyerly HK, Gilboa E, Thomas E, Nair SK. Morse MA, et al. Cancer Res. 1998 Jul 15;58(14):2965-8. Cancer Res. 1998. PMID: 9679955

4

Migration of human dendritic cells after injection in patients with metastatic malignancies.

Morse MA, Coleman RE, Akabani G, Niehaus N, Coleman D, Lyerly HK. Morse MA, et al. Cancer Res. 1999 Jan 1;59(1):56-8. Cancer Res. 1999. PMID: 9892184

5

Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA.

Nair SK, Hull S, Coleman D, Gilboa E, Lyerly HK, Morse MA. Nair SK, et al. Among authors: morse ma. Int J Cancer. 1999 Jul 2;82(1):121-4. doi: 10.1002/(sici)1097-0215(19990702)82:1<121::aid-ijc20>3.0.co;2-x. Int J Cancer. 1999. PMID: 10360830

6

The role of IL-13 in the generation of dendritic cells in vitro.

Morse MA, Lyerly HK, Li Y. Morse MA, et al. J Immunother. 1999 Nov;22(6):506-13. doi: 10.1097/00002371-199911000-00005. J Immunother. 1999. PMID: 10570749

7

Dendritic cell-based immunization for cancer therapy.

Morse MA, Lyerly HK. Morse MA, et al. Adv Exp Med Biol. 2000;465:335-46. doi: 10.1007/0-306-46817-4_28. Adv Exp Med Biol. 2000. PMID: 10810637 Review. No abstract available.

8

Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancer.

Morse MA, Nair S, Fernandez-Casal M, Deng Y, St Peter M, Williams R, Hobeika A, Mosca P, Clay T, Cumming RI, Fisher E, Clavien P, Proia AD, Niedzwiecki D, Caron D, Lyerly HK. Morse MA, et al. J Clin Oncol. 2000 Dec 1;18(23):3883-93. doi: 10.1200/JCO.2000.18.23.3883. J Clin Oncol. 2000. PMID: 11099317 Clinical Trial.

9

Assays for monitoring cellular immune responses to active immunotherapy of cancer.

Clay TM, Hobeika AC, Mosca PJ, Lyerly HK, Morse MA. Clay TM, et al. Among authors: morse ma. Clin Cancer Res. 2001 May;7(5):1127-35. Clin Cancer Res. 2001. PMID: 11350875 Review.

10

Carcinoembryonic antigen peptide-pulsed dendritic cells in patients with metastatic cancer.

Lyerly HK, Morse MA. Lyerly HK, et al. Among authors: morse ma. Clin Lung Cancer. 1999 Aug;1(1):70-2. doi: 10.3816/clc.1999.n.005. Clin Lung Cancer. 1999. PMID: 14725754 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

402 results

Search Page

Filters